Non-Hodgkin's lymphoma (NHL) accounts for 4% of new cancer cases and 3% of cancer deaths in both men and women [1]. The majority of patients present with painless peripheral lymphadenopathy, though...
No takes yet. Share an insight, caveat, or question.
Krem et al. (2007) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: